CBD Reduced Gut Symptoms of Opioid Withdrawal in Mice
CBD dose-dependently reduced gastrointestinal symptoms of opioid withdrawal in both male and female mice, suggesting a potential therapeutic target for managing withdrawal discomfort.
Quick Facts
What This Study Found
CBD at 10, 30, and 100 mg/kg dose-dependently reduced gastrointestinal symptoms (diarrhea, fecal output, weight loss) during both precipitated and spontaneous oxycodone withdrawal in male mice and during precipitated withdrawal in female mice. Effects on other withdrawal symptoms (jumping, paw tremors) were less consistent.
Key Numbers
CBD tested at 10, 30, and 100 mg/kg. Oxycodone escalated from 9 to 33 mg/kg over 8 days. Male mice showed withdrawal effects in both precipitated and spontaneous conditions; female mice only showed precipitated withdrawal effects. GI symptom reduction was consistent across both sexes in precipitated withdrawal.
How They Did This
Mice received escalating oxycodone doses over 8 days, then underwent either naloxone-precipitated or spontaneous withdrawal. CBD was administered 60 minutes before testing at 0, 10, 30, or 100 mg/kg. Gastrointestinal symptoms, somatic symptoms, and negative affect behaviors were measured.
Why This Research Matters
Opioid withdrawal is a major driver of continued drug use, and current treatments have limitations. The gastrointestinal symptoms (nausea, diarrhea, cramping) are among the most distressing. Finding that CBD specifically targets these symptoms opens a potential complementary treatment avenue.
The Bigger Picture
The opioid crisis has driven interest in non-opioid approaches to managing withdrawal. CBD, which is already available clinically and has a favorable safety profile, could potentially be integrated into withdrawal management protocols if these findings translate to humans.
What This Study Doesn't Tell Us
Animal study results may not translate to humans. Doses used were relatively high. Female mice showed less robust withdrawal syndrome overall, making it harder to evaluate CBD's effects in that group. The study did not examine long-term outcomes or relapse.
Questions This Raises
- ?Why did female mice show a less pronounced withdrawal syndrome?
- ?Would CBD be effective at clinically relevant doses in humans?
- ?Could CBD be combined with existing withdrawal medications for additive benefit?
Trust & Context
- Key Stat:
- CBD reduced GI withdrawal symptoms at all three doses tested
- Evidence Grade:
- Well-designed animal study with dose-response data and sex comparisons, but preclinical findings require human validation.
- Study Age:
- 2024 study (published 2022 online, journal 2024)
- Original Title:
- Cannabidiol Reduced the Severity of Gastrointestinal Symptoms of Opioid Withdrawal in Male and Female Mice.
- Published In:
- Cannabis and cannabinoid research, 9(2), 547-560 (2024)
- Authors:
- Scicluna, Rhianne L, Wilson, Bianca B, Thelaus, Samuel H, Arnold, Jonathon C, McGregor, Iain S, Bowen, Michael T
- Database ID:
- RTHC-05692
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Can CBD help with opioid withdrawal?
In mice, CBD reduced the gastrointestinal symptoms of opioid withdrawal (diarrhea, weight loss) in a dose-dependent manner. Human studies are still needed.
Which opioid withdrawal symptoms did CBD affect?
CBD was most effective against gastrointestinal symptoms. It had less consistent effects on other withdrawal behaviors like jumping and paw tremors.
Read More on RethinkTHC
- 30-days-without-weed
- 6-months-sober-weed-what-to-expect
- 90-days-no-weed
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- benefits-of-quitting-weed
- boredom-after-quitting-weed
- boredom-after-quitting-weed-nothing-fun
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- creativity-without-weed-quitting-artist-musician
- hobbies-after-quitting-weed
- identity-after-quitting-weed
- leaving-stoner-culture-identity
- medical-benefits-of-cannabis
- money-saved-quitting-weed-calculator
- one-year-sober-weed
- quitting-weed-before-surgery
- quitting-weed-creativity
- quitting-weed-face-changes-skin
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- quitting-weed-weight-loss-gain
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-05692APA
Scicluna, Rhianne L; Wilson, Bianca B; Thelaus, Samuel H; Arnold, Jonathon C; McGregor, Iain S; Bowen, Michael T. (2024). Cannabidiol Reduced the Severity of Gastrointestinal Symptoms of Opioid Withdrawal in Male and Female Mice.. Cannabis and cannabinoid research, 9(2), 547-560. https://doi.org/10.1089/can.2022.0036
MLA
Scicluna, Rhianne L, et al. "Cannabidiol Reduced the Severity of Gastrointestinal Symptoms of Opioid Withdrawal in Male and Female Mice.." Cannabis and cannabinoid research, 2024. https://doi.org/10.1089/can.2022.0036
RethinkTHC
RethinkTHC Research Database. "Cannabidiol Reduced the Severity of Gastrointestinal Symptom..." RTHC-05692. Retrieved from https://rethinkthc.com/research/scicluna-2024-cannabidiol-reduced-the-severity
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.